logo

For the Inventor, By the Inventor

Brooklyn, NY, United States of America

Anderson Gaweco

This inventor holds 8 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignees: Innov17 LLC, Innov88 LLC. Active years: 2015-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anderson Gaweco. Retrieved from https://idiyas.com/inventor/anderson-gaweco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 25.0

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • New York, NY (US) (2016 - 2017)
  • Brooklyn, NY (US) (2015 - 2018)

Company Filing History:

goldMedal6 out of 6 
 
Innov17 LLC
 patents
silverMedal2 out of 2 
 
Innov88 LLC
 patents

Years Active: 2015-2018

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 9884847 - Indazole retinoic acid receptor-related orphan receptor modulators and uses thereof (2018-02-06),
2. 9771374 - Benzimidazole retinoic acid receptor-related orphan receptor modulators and uses thereof (2017-09-26),
3. 9708268 - ROR modulators and their uses (2017-07-18),
4. 9701663 - Sulfonamide retinoic acid receptor-related orphan receptor modulators and uses thereof (2017-07-11),
5. 9447069 - ROR modulators and their uses (2016-09-20),
6. 9321750 - ROR modulators and their uses (2016-04-26),
7. 9133164 - MIF inhibitors and their uses (2015-09-15),
8. 9050334 - MIF inhibitors and their uses (2015-06-09),

Title: Anderson Gaweco: Innovator in Pharmaceutical Modulators

Introduction

Anderson Gaweco is a notable inventor based in Brooklyn, NY, who has made significant contributions to the field of pharmaceuticals. With a total of 8 patents to his name, Gaweco has focused on developing compounds that target specific diseases and disorders related to retinoic acid receptors.

Latest Patents

His latest patents include "Indazole retinoic acid receptor-related orphan receptor modulators and uses thereof." This patent provides compounds of specific formulas, along with pharmaceutically acceptable salts, which are useful for treating diseases regulated by Retinoic Acid Receptor-Related Orphan Receptors. Another significant patent is "Benzimidazole retinoic acid receptor-related orphan receptor modulators and uses thereof," which similarly outlines compounds and their applications in treating related disorders.

Career Highlights

Throughout his career, Gaweco has worked with various companies, including Innov17 LLC and Innov88 LLC. His work has been instrumental in advancing pharmaceutical research and development, particularly in the area of receptor modulators.

Collaborations

Some of his notable coworkers include Jefferson Wright Tilley and James Robert Blinn, who have collaborated with him on various projects.

Conclusion

Anderson Gaweco's innovative work in pharmaceutical modulators has made a significant impact in the field, showcasing his dedication to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…